Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCT
3726
DELISTED
First Trust Senior Floating Rate Income Fund II
FCT
| $4.56M | ﹤0.01% |
456,720
-287,538
| -39% | -$2.93M |
|
|
RMM
3727
RiverNorth Managed Duration Municipal Income Fund
RMM
$285M
| $4.55M | ﹤0.01% |
311,552
+11,085
| +4% | +$178K |
|
|
VERV
3728
DELISTED
Verve Therapeutics
VERV
| $4.54M | ﹤0.01% |
132,326
-65,220
| -33% | -$2.08M |
|
|
PARAA
3729
DELISTED
Paramount Global Class A
PARAA
| $4.53M | ﹤0.01% |
210,423
+45,599
| +28% | +$1.23M |
|
|
BNT
3730
Brookfield Wealth Solutions
BNT
$13B
| $4.52M | ﹤0.01% |
165,887
+19,656
| +13% | +$630K |
|
3731
Banc of California
BANC
$3.13B
| $4.52M | ﹤0.01% |
283,040
-12,032
| -4% | -$210K |
|
|
NSL
3732
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $4.51M | ﹤0.01% |
966,782
+153,230
| +19% | +$756K |
|
3733
Full Truck Alliance
YMM
$9.14B
| $4.5M | ﹤0.01% |
687,832
-438,456
| -39% | -$3.38M |
|
3734
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
| $4.5M | ﹤0.01% |
63,463
+46,476
| +274% | +$3.68M |
|
3735
York Water
YORW
$541M
| $4.49M | ﹤0.01% |
116,959
-1,259
| -1% | -$54K |
|
3736
N-able
NABL
$650M
| $4.49M | ﹤0.01% |
486,533
-109,147
| -18% | -$1.06M |
|
|
BLE
3737
DELISTED
BlackRock Municipal Income Trust II
BLE
| $4.48M | ﹤0.01% |
447,817
+125,698
| +39% | +$1.41M |
|
3738
Afya
AFYA
$1.27B
| $4.47M | ﹤0.01% |
329,659
+99,443
| +43% | +$1.19M |
|
3739
Myers Industries
MYE
$1.24B
| $4.47M | ﹤0.01% |
271,203
-23,091
| -8% | -$476K |
|
3740
Pliant Therapeutics
PLRX
$66.3M
| $4.46M | ﹤0.01% |
213,693
-142,346
| -40% | -$2.72M |
|
3741
iShares MSCI Austria ETF
EWO
$188M
| $4.46M | ﹤0.01% |
287,451
+31,353
| +12% | +$553K |
|
3742
First Trust Eurozone AlphaDEX
FEUZ
$134M
| $4.46M | ﹤0.01% |
153,544
-85,240
| -36% | -$2.8M |
|
3743
Sight Sciences
SGHT
$448M
| $4.45M | ﹤0.01% |
701,083
+463,240
| +195% | +$3.92M |
|
|
AD
3744
Array Digital Infrastructure
AD
$3.11B
| $4.45M | ﹤0.01% |
171,009
-1,099
| -0.6% | -$31.5K |
|
|
GCV
3745
Gabelli Convertible and Income Securities Fund
GCV
$95.9M
| $4.44M | ﹤0.01% |
894,246
-40,696
| -4% | -$220K |
|
|
SRV
3746
NXG Cushing Midstream Energy Fund
SRV
$226M
| $4.44M | ﹤0.01% |
136,153
+25,533
| +23% | +$821K |
|
|
KYNB
3747
Kyntra Bio
KYNB
$28.5M
| $4.43M | ﹤0.01% |
13,613
-12,418
| -48% | -$4M |
|
3748
Invesco S&P MidCap 400 Pure Value ETF
RFV
$343M
| $4.42M | ﹤0.01% |
55,471
-99,117
| -64% | -$8.67M |
|
3749
iShares MSCI Malaysia ETF
EWM
$330M
| $4.42M | ﹤0.01% |
218,921
-794
| -0.4% | -$17.4K |
|
|
BLU
3750
DELISTED
BELLUS Health Inc.
BLU
| $4.41M | ﹤0.01% |
417,021
+294,293
| +240% | +$3.13M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.